Clinical Trial Update: Gene-by-Smoking Interactions and Risk of Atherosclerosis - Ancillary to ARIC

View source ↗

Summary

Clinical trial update examining gene-by-smoking interactions and risk of atherosclerosis as an ancillary ARIC study; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Diseases
• Carotid Artery Disease
• Cerebral Arteriosclerosis
• Coronary Artery Disease
• Heart Disease
• Peripheral Vascular Disease
• Stroke

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Atherosclerosis, Cardiovascular Diseases | Status: COMPLETED